[HTML][HTML] Features, evaluation, and treatment of coronavirus (COVID-19)

M Cascella, M Rajnik, A Aleem, SC Dulebohn… - 2020 - europepmc.org
Objectives: Screen individuals based on exposure and symptom criteria to identify potential
COVID-19 cases. Identify the clinical features and radiological findings expected in patients …

[HTML][HTML] Shared decision-making in the management of patients with inflammatory bowel disease

K Song, D Wu - World journal of gastroenterology, 2022 - ncbi.nlm.nih.gov
The rapid progress of research into inflammatory bowel disease (IBD) has resulted in
increasingly more treatment options. Different options have different advantages and …

Pengetahuan dan sikap masyarakat dalam pencegahan COVID-19

E Suprayitno, S Rahmawati… - Journal Of Health …, 2020 - ejournalwiraraja.com
METODE PENELITIAN Penelitian ini merupakan jenis deskriptif, dengan pendekatan Cross
sectional non analitik. Pengumpulan data dilakukan menggunakan kuesioner dengan …

[HTML][HTML] Global prevalence of COVID-19-associated mucormycosis (CAM): living systematic review and meta-analysis

S Hussain, A Riad, A Singh, J Klugarová, B Antony… - Journal of Fungi, 2021 - mdpi.com
Mucormycosis, a secondary fungal infection, gained much attention in the ongoing COVID-
19 pandemic. This deadly infection has a high all-cause mortality rate and imposes a …

Implications of SARS‐CoV‐2 infection for neurogastroenterology

G Marasco, MV Lenti, C Cremon… - …, 2021 - Wiley Online Library
Abstract Background Coronavirus disease 2019 (COVID‐19) is associated with
gastrointestinal and hepatic manifestation in up to one fifth of patients. Severe acute …

Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911 …

V Ivashkin, V Fomin, S Moiseev, M Brovko… - Probiotics and …, 2021 - Springer
The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …

Gastrointestinal symptoms and the severity of COVID‐19: Disorders of gut–brain interaction are an outcome

R Ebrahim Nakhli, A Shanker, I Sarosiek… - …, 2022 - Wiley Online Library
Background Many of the studies on COVID‐19 severity and its associated symptoms focus
on hospitalized patients. The aim of this study was to investigate the relationship between …

Clostridioides difficile infection (CDI) during the COVID-19 pandemic

P Spigaglia - Anaerobe, 2022 - Elsevier
The ongoing coronavirus disease (COVID-19) pandemic has dramatically tested healthcare
systems around the world, with serious repercussions on the measures of prevention and …

Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and …

M Shehab, F Alrashed, S Shuaibi… - BMJ open …, 2021 - bmjopengastro.bmj.com
Background and aims Patients infected with the SARS-CoV-2 usually report fever and
respiratory symptoms. However, multiple gastrointestinal (GI) manifestations such as …

[HTML][HTML] Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

I Lopez-Mendez, J Aquino-Matus, SMB Gall… - Annals of …, 2021 - Elsevier
Abstract Introduction and Objectives Liver function tests (LFT) abnormalities are reported in
up to 50% of COVID-19 patients, and metabolic comorbidities are associated with poorer …